SG163588A1 - Methods for identifying agents and conditions that modulate neurogenesis - Google Patents
Methods for identifying agents and conditions that modulate neurogenesisInfo
- Publication number
- SG163588A1 SG163588A1 SG201004947-6A SG2010049476A SG163588A1 SG 163588 A1 SG163588 A1 SG 163588A1 SG 2010049476 A SG2010049476 A SG 2010049476A SG 163588 A1 SG163588 A1 SG 163588A1
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- conditions
- identifying agents
- modulate neurogenesis
- neurogenesis
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5073—Stem cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Developmental Biology & Embryology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US69790505P | 2005-07-08 | 2005-07-08 | |
US76388306P | 2006-01-31 | 2006-01-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG163588A1 true SG163588A1 (en) | 2010-08-30 |
Family
ID=37400950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG201004947-6A SG163588A1 (en) | 2005-07-08 | 2006-07-07 | Methods for identifying agents and conditions that modulate neurogenesis |
Country Status (8)
Country | Link |
---|---|
US (1) | US20070015138A1 (de) |
EP (2) | EP1904843A2 (de) |
JP (1) | JP2009500043A (de) |
AU (1) | AU2006269231A1 (de) |
CA (1) | CA2614289A1 (de) |
NZ (1) | NZ565683A (de) |
SG (1) | SG163588A1 (de) |
WO (1) | WO2007008758A2 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US20070244143A1 (en) * | 2006-03-08 | 2007-10-18 | Braincells, Inc | Modulation of neurogenesis by nootropic agents |
US20090197823A1 (en) * | 2006-05-09 | 2009-08-06 | Braincells, Inc. | Aliskiren modulation of neurogenesis |
AU2007249435A1 (en) * | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
KR20090064418A (ko) * | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
CA2663347A1 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | Ppar mediated modulation of neurogenesis |
US20080171750A1 (en) * | 2007-01-11 | 2008-07-17 | Braincells, Inc. | Modulation Of Neurogenesis With Use of Modafinil |
US20080188457A1 (en) * | 2007-02-02 | 2008-08-07 | Braincells, Inc. | Modulation of Neurogenesis with Biguanides and GSK3-beta Agents |
EP2197431A4 (de) * | 2007-09-17 | 2013-03-27 | Olas Pharmaceuticals Inc | Wachstumshormon-, dhea- und cortisolmodulation mit positiven modulatoren der ampa-glutamatrezeptoren |
US20090239834A1 (en) * | 2008-03-21 | 2009-09-24 | Braincells, Inc. | Mcc-257 modulation of neurogenesis |
WO2010099217A1 (en) | 2009-02-25 | 2010-09-02 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
US10386360B2 (en) | 2009-03-13 | 2019-08-20 | University Of Central Florida Research Foundation, Inc. | Bio-microelectromechanical system transducer and associated methods |
JP5783504B2 (ja) * | 2009-03-30 | 2015-09-24 | 国立研究開発法人国立環境研究所 | 胎生プログラミングに対する影響を評価するための方法 |
US8815584B1 (en) | 2009-04-23 | 2014-08-26 | University Of Central Florida Research Foundation, Inc. | Method of co-culturing mammalian muscle cells and motoneurons |
US9163216B1 (en) | 2009-04-23 | 2015-10-20 | University Of Central Florida Research Foundation, Inc. | Method for culturing skeletal muscle for tissue engineering |
US8828721B1 (en) | 2009-05-28 | 2014-09-09 | University Of Central Florida Research Foundation, Inc. | Method of myelinating isolated motoneurons |
US9404140B1 (en) | 2009-11-03 | 2016-08-02 | The University Of Central Florida Research Foundation, Inc. | Patterned cardiomyocyte culture on microelectrode array |
CA2788905A1 (en) | 2010-02-05 | 2011-08-11 | University Of Central Florida Research Foundation, Inc. | Model and methods for identifying points of action in electrically active cells |
CA2798777C (en) | 2010-04-23 | 2016-09-06 | University Of Central Florida Research Foundation, Inc. | Formation of neuromuscular junctions in a defined system |
US9617517B2 (en) * | 2011-05-02 | 2017-04-11 | National University Corporation Kumamoto University | Small chemical compound which promotes induction of differentiation of stem cells into insulin-producing cells and method for inducing differentiation of stem cells into insulin-producing cells using said small chemical compound |
WO2012158923A1 (en) * | 2011-05-17 | 2012-11-22 | University Of Central Florida Research Foundation, Inc. | Stable electrically active neurons from adult tissue |
CN103842498A (zh) * | 2011-08-19 | 2014-06-04 | 桑比欧公司 | 神经源性因子和胶质生成性因子及其测定 |
WO2013033246A2 (en) | 2011-08-29 | 2013-03-07 | Braincells, Inc. | Novel benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof |
US20130224782A1 (en) * | 2012-02-29 | 2013-08-29 | Chenzhong Kuang | Neurogenesis screening method and system using adipose tissue derived stem cells |
EP2951281B1 (de) | 2013-01-30 | 2018-06-27 | University of Central Florida Research Foundation, Inc. | System und verfahren zur nachahmung der herzfunktion |
CA2936486A1 (en) * | 2013-02-13 | 2014-08-21 | Cell Cure Neurosciences Ltd. | High throughput screening of agents on dopaminergic neurons |
US20160340647A1 (en) * | 2014-01-27 | 2016-11-24 | Biodemak Llc | Compositions and methods for inducing differentiation of stem cells |
US10935541B2 (en) | 2014-08-07 | 2021-03-02 | University Of Central Florida Research Foundation, Inc. | Devices and methods comprising neuromuscular junctions |
Family Cites Families (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2364833A (en) | 1941-12-06 | 1944-12-12 | Merck & Co Inc | N-allylnormorphine and processes for its production |
US2891954A (en) | 1953-07-30 | 1959-06-23 | Merck & Co Inc | Process for preparing n-allylnormorphine |
US3454554A (en) * | 1960-10-14 | 1969-07-08 | Colgate Palmolive Co | Aminoalkyliminodibenzyl compounds |
US3254088A (en) | 1961-03-14 | 1966-05-31 | Lewenstein | Morphine derivative |
NL127069C (de) | 1961-10-10 | |||
US3332950A (en) | 1963-03-23 | 1967-07-25 | Endo Lab | 14-hydroxydihydronormorphinone derivatives |
NL129434C (de) | 1966-03-12 | |||
US3885046A (en) * | 1969-12-04 | 1975-05-20 | Burroughs Wellcome Co | Meta chloro or fluoro substituted alpha-T-butylaminopropionphenones in the treatment of depression |
BE759838A (fr) * | 1969-12-04 | 1971-06-03 | Wellcome Found | Cetones a activite biologique |
US3821249A (en) * | 1970-03-13 | 1974-06-28 | En Nom Collectif Science Union | Dibenzothiazefin derivatives |
US3758528A (en) | 1970-03-13 | 1973-09-11 | Science Union & Cie | Tricyclic compounds |
US3814768A (en) * | 1971-11-26 | 1974-06-04 | Lewenstein E | 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts |
US3896226A (en) * | 1971-11-26 | 1975-07-22 | Lewinstein Evalina | 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts thereof, and use of the same as a narcotic antagonist |
GB1422263A (en) | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
US4314081A (en) | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
US4194009A (en) * | 1974-01-10 | 1980-03-18 | Eli Lilly And Company | Aryloxyphenylpropylamines for obtaining a psychotropic effect |
US4191771A (en) * | 1974-09-06 | 1980-03-04 | Eli Lilly And Company | Analgesic method using 1,3,4-trisubstituted-4-arylpiperidines |
NL7503310A (nl) | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
NL189199C (nl) * | 1975-04-05 | 1993-02-01 | Akzo Nv | Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten. |
GB1497306A (en) * | 1975-07-03 | 1978-01-05 | Leo Ab | Preparation of lofepramine and its hydrochloride |
GB1526331A (en) * | 1976-01-14 | 1978-09-27 | Kefalas As | Phthalanes |
IL56369A (en) * | 1978-01-20 | 1984-05-31 | Erba Farmitalia | Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them |
US4536518A (en) * | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
US4338317A (en) | 1981-03-16 | 1982-07-06 | Mead Johnson & Company | Phenoxyethyl-1,2,4,-triazol-3-one antidepressants |
FR2508035A1 (fr) | 1981-06-23 | 1982-12-24 | Fabre Sa Pierre | Derives d'aryl-1-aminomethyl-2 cyclopropanes carboxamides (z), leur preparation et leur application en tant que medicaments utiles dans le traitement des troubles du systeme nerveux central |
US4761501A (en) * | 1983-10-26 | 1988-08-02 | American Home Products Corporation | Substituted phenylacetamides |
US4956388A (en) | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
US4891379A (en) | 1987-04-16 | 1990-01-02 | Kabushiki Kaisha Kobe Seikosho | Piperidine opioid antagonists |
US4816586A (en) * | 1987-07-29 | 1989-03-28 | Regents Of The University Of Minnesota | Delta opioid receptor antagonists |
US5264563A (en) * | 1990-08-24 | 1993-11-23 | Ixsys Inc. | Process for synthesizing oligonucleotides with random codons |
US5851832A (en) * | 1991-07-08 | 1998-12-22 | Neurospheres, Ltd. | In vitro growth and proliferation of multipotent neural stem cells and their progeny |
US5750376A (en) * | 1991-07-08 | 1998-05-12 | Neurospheres Holdings Ltd. | In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny |
US7361505B1 (en) * | 1991-07-08 | 2008-04-22 | Neurospheres Holdings Ltd. | Multipotent neural stem cell compositions |
US6294346B1 (en) * | 1991-07-08 | 2001-09-25 | Neurospheres Holdings, Ltd. | Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents |
US6497872B1 (en) * | 1991-07-08 | 2002-12-24 | Neurospheres Holdings Ltd. | Neural transplantation using proliferated multipotent neural stem cells and their progeny |
WO1993002707A1 (de) | 1991-08-06 | 1993-02-18 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Neue antidiarrhoica |
GB9202238D0 (en) | 1992-02-03 | 1992-03-18 | Wellcome Found | Compounds |
US5766948A (en) * | 1993-01-06 | 1998-06-16 | The Regents Of The University Of California | Method for production of neuroblasts |
US5753506A (en) * | 1996-05-23 | 1998-05-19 | Cns Stem Cell Technology, Inc. | Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals |
US5968829A (en) * | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
EP1028958A4 (de) * | 1997-10-22 | 2001-07-18 | Lilly Co Eli | Arylpiperazine als inhibitoren der serotoninwiederaufnahme und 5-ht1d alpha antagonisten |
US6165783A (en) * | 1997-10-24 | 2000-12-26 | Neuro Spheres Holdings Ltd. | Erythropoietin-mediated neurogenesis |
TWI244481B (en) | 1998-12-23 | 2005-12-01 | Pfizer | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
US6503905B1 (en) | 1998-12-29 | 2003-01-07 | Pfizer Inc | 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
US6767738B1 (en) | 1999-02-11 | 2004-07-27 | The Salk Institute For Biological Studies | Method of isolating adult mammalian CNS-derived progenitor stem cells using density gradient centrifugation |
EP1038872A1 (de) | 1999-02-22 | 2000-09-27 | Pfizer Products Inc. | 4-Phenyl-4-heteroarylpiperdine Derivate als Opioid-Rezeptorligande |
US6238922B1 (en) * | 1999-02-26 | 2001-05-29 | Stemcells, Inc. | Use of collagenase in the preparation of neural stem cell cultures |
US6342496B1 (en) | 1999-03-01 | 2002-01-29 | Sepracor Inc. | Bupropion metabolites and methods of use |
EP1257560A4 (de) * | 2000-02-01 | 2003-10-01 | Human Genome Sciences Inc | Bcl-2 ähnliche polynukleotide, polypeptide und antikörper |
IL152741A0 (en) * | 2000-05-17 | 2003-06-24 | Geron Corp | Neural progenitor cell populations |
US7250294B2 (en) * | 2000-05-17 | 2007-07-31 | Geron Corporation | Screening small molecule drugs using neural cells differentiated from human embryonic stem cells |
WO2002083877A1 (en) * | 2001-04-11 | 2002-10-24 | Stem Cell Therapeutics Inc. | Production of tyrosine hydroxylase positive neurons |
US20030022369A1 (en) * | 2001-05-18 | 2003-01-30 | Helen Fillmore | Differentiation of specialized dermal and epidermal cells into neuronal cells |
WO2002102988A2 (en) * | 2001-06-18 | 2002-12-27 | Psychiatric Genomics, Inc. | Method for neural stem cell differentiation using 5ht-1a agonists |
EP1423504B1 (de) * | 2001-08-08 | 2009-09-23 | Levesque Biosciences, Inc. | Zusammensetzungen und verfahren zur isolierung, vermehrung und differenzierung nicht-embryonale menschlicher stammzellen und deren verwendungen |
AU2003250705A1 (en) * | 2002-07-31 | 2004-02-16 | Stem Cell Therapeutics Inc. | Method of enhancing neural stem cell proliferation, differentiation, and survival using pituitary adenylate cyclase activating polypeptide (pacap) |
US8293488B2 (en) * | 2002-12-09 | 2012-10-23 | Neuralstem, Inc. | Method for screening neurogenic agents |
EP1576134B1 (de) * | 2002-12-09 | 2013-03-06 | Judith Kelleher-Andersson | Verfahren zur entdeckung neurogener wirkstoffe |
US20050019801A1 (en) * | 2003-06-04 | 2005-01-27 | Curis, Inc. | Stem cell-based methods for identifying and characterizing agents |
EP2275096A3 (de) * | 2005-08-26 | 2011-07-13 | Braincells, Inc. | Neurogenese durch modulation des Muscarinrezeptors |
WO2007030697A2 (en) * | 2005-09-07 | 2007-03-15 | Braincells, Inc. | Modulation of neurogenesis by hdac inhibition |
WO2007047978A2 (en) * | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by pde inhibition |
CA2625210A1 (en) * | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
WO2007092535A2 (en) * | 2006-02-07 | 2007-08-16 | Mitsubishi Tanabe Pharma Corporation | 4-acylaminopyridine derivative mediated neurogenesis |
US20070244143A1 (en) * | 2006-03-08 | 2007-10-18 | Braincells, Inc | Modulation of neurogenesis by nootropic agents |
US7858611B2 (en) * | 2006-05-09 | 2010-12-28 | Braincells Inc. | Neurogenesis by modulating angiotensin |
AU2007249435A1 (en) * | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
KR20090064418A (ko) * | 2006-09-08 | 2009-06-18 | 브레인셀즈 인코퍼레이션 | 4-아실아미노피리딘 유도체 포함 조합물 |
CA2663347A1 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | Ppar mediated modulation of neurogenesis |
AU2007299726A1 (en) * | 2006-09-22 | 2008-03-27 | Braincells, Inc. | Combination comprising an HMG-COA reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis |
US20080108574A1 (en) * | 2006-09-27 | 2008-05-08 | Braincells, Inc. | Melanocortin receptor mediated modulation of neurogenesis |
WO2008083204A2 (en) * | 2006-12-28 | 2008-07-10 | Braincells, Inc. | Modulation of neurogenesis by melatoninergic ligands |
US20080171750A1 (en) * | 2007-01-11 | 2008-07-17 | Braincells, Inc. | Modulation Of Neurogenesis With Use of Modafinil |
US20080188457A1 (en) * | 2007-02-02 | 2008-08-07 | Braincells, Inc. | Modulation of Neurogenesis with Biguanides and GSK3-beta Agents |
-
2006
- 2006-07-07 NZ NZ565683A patent/NZ565683A/en not_active IP Right Cessation
- 2006-07-07 EP EP06800028A patent/EP1904843A2/de not_active Withdrawn
- 2006-07-07 AU AU2006269231A patent/AU2006269231A1/en not_active Abandoned
- 2006-07-07 SG SG201004947-6A patent/SG163588A1/en unknown
- 2006-07-07 EP EP10015900A patent/EP2317316A3/de not_active Withdrawn
- 2006-07-07 CA CA002614289A patent/CA2614289A1/en not_active Abandoned
- 2006-07-07 JP JP2008520437A patent/JP2009500043A/ja active Pending
- 2006-07-07 US US11/482,528 patent/US20070015138A1/en not_active Abandoned
- 2006-07-07 WO PCT/US2006/026677 patent/WO2007008758A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2007008758A3 (en) | 2007-03-15 |
AU2006269231A1 (en) | 2007-01-18 |
CA2614289A1 (en) | 2007-01-18 |
EP1904843A2 (de) | 2008-04-02 |
JP2009500043A (ja) | 2009-01-08 |
EP2317316A3 (de) | 2011-06-15 |
EP2317316A2 (de) | 2011-05-04 |
US20070015138A1 (en) | 2007-01-18 |
WO2007008758A2 (en) | 2007-01-18 |
NZ565683A (en) | 2011-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG163588A1 (en) | Methods for identifying agents and conditions that modulate neurogenesis | |
NL301145I1 (de) | ||
SG169324A1 (en) | Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype | |
MX2020001944A (es) | Poblaciones de celula madre de la placenta. | |
IL249263B (en) | A method for extracorporeal organ treatment | |
MY159971A (en) | Multipotent/pluripotent cells and methods | |
MY180473A (en) | Imaging and evaluating embryos, oocytes, and stem cells | |
WO2006070370A3 (en) | Stem cells culture systems | |
GB2449772A (en) | Large scale production of stem cells | |
MX2009010847A (es) | Reprogramacion de celulas somaticas. | |
CY1116768T1 (el) | Συνθεσεις οι οποιες περιεχουν βλαστοκυτταρα θηλυκης γαμετικης σειρας και μεθοδοι χρησης αυτων | |
WO2008036374A3 (en) | Allogeneic stem cell transplants in non-conditioned recipients | |
WO2006052646A3 (en) | Derivation of embryonic stem cells | |
IL192762A0 (en) | Method for identifying cell differentiation factors | |
GB2442406A (en) | Mesoderm and definitive endoderm cell populations | |
TW200716624A (en) | Compounds for modulating TRPV3 function | |
WO2007075807A3 (en) | Methods for the directed differentiation of embryonic stem cell | |
WO2007027905A3 (en) | Human renal stem cells | |
MX2007005202A (es) | Polisacaridos de estreptococo modificados y usos de los mismos. | |
IL179441A (en) | Method of measuring the activity of egln enzyme and of identifying an agent that modulates activity of said enzyme | |
AU2019268061A1 (en) | Placental stem cell populations | |
WO2004015077A3 (en) | Compositions and methods for neural differentiation of embryonic stem cells | |
MX2007002277A (es) | Metodos para formar retinoides y usos de los mismos. | |
WO2005089420A3 (en) | Expansion of neural stem cells with lif | |
MY162185A (en) | Alumina particles and methods of making the same |